Correlation Between Lindblad Expeditions and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lindblad Expeditions and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lindblad Expeditions and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lindblad Expeditions Holdings and Spyre Therapeutics, you can compare the effects of market volatilities on Lindblad Expeditions and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lindblad Expeditions with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lindblad Expeditions and Spyre Therapeutics.

Diversification Opportunities for Lindblad Expeditions and Spyre Therapeutics

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lindblad and Spyre is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Lindblad Expeditions Holdings and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Lindblad Expeditions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lindblad Expeditions Holdings are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Lindblad Expeditions i.e., Lindblad Expeditions and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Lindblad Expeditions and Spyre Therapeutics

Given the investment horizon of 90 days Lindblad Expeditions Holdings is expected to generate 0.8 times more return on investment than Spyre Therapeutics. However, Lindblad Expeditions Holdings is 1.26 times less risky than Spyre Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  1,206  in Lindblad Expeditions Holdings on October 25, 2024 and sell it today you would lose (61.00) from holding Lindblad Expeditions Holdings or give up 5.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lindblad Expeditions Holdings  vs.  Spyre Therapeutics

 Performance 
       Timeline  
Lindblad Expeditions 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Lindblad Expeditions Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Lindblad Expeditions exhibited solid returns over the last few months and may actually be approaching a breakup point.
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Lindblad Expeditions and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lindblad Expeditions and Spyre Therapeutics

The main advantage of trading using opposite Lindblad Expeditions and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lindblad Expeditions position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind Lindblad Expeditions Holdings and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon